Erratum: Separable bilayer microfiltration device for viable label-free enrichment of circulating tumour cells (Biomedical Engineering Tumour Biomarkers (2014) 4 (7392) 10.1038/srep07392);Separable bilayer microfiltration device for viable label-free enrichment of circulating tumour cells

Scientific Reports

Volumn 4, Issue , 2014, Pages 7967-

  Zhou, Ming Da ^a   Hao, Sijie ^a   Williams, Anthony J ^b   Harouaka, Ramdane A ^a   Schrand, Brett ^b   Rawal, Siddarth ^b   Ao, Zheng ^b   Brenneman, Randall ^b   Gilboa, Eli ^b   Lu, Bo ^c   Wang, Shuwen ^d   Zhu, Jiyue ^d   Datar, Ram ^b   Cote, Richard ^b   Tai, Yu Chong ^c   Zheng, Si Yang ^a  

^a The Pennsylvania State University   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL SEPARATION; CELL SURVIVAL; DEVICES; DISEASE MODEL; HUMAN; MICROPORE FILTER; MOUSE; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; TUMOR CELL LINE; TUMOR EMBOLISM;

ANIMALS; CELL LINE, TUMOR; CELL SEPARATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICROPORE FILTERS; NEOPLASTIC CELLS, CIRCULATING; REPRODUCIBILITY OF RESULTS;

EID: 84923238726     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07967     Document Type: Erratum

References (51)

1. Mehlen, P. & Puisieux, A. Metastasis: a question of life or death. Nat Rev Cancer 6, 449-458 (2006).
2. Harouaka, R., Kang, Z., Zheng, S.-Y. & Cao, L. Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications. Pharmacology Therapeutics 141, 209-221 (2014).
3. Pantel, K. & Alix-Panabieres, C. The clinical significance of circulating tumor cells. Nat Clin Prac Oncol. 4, 62-63 (2007).
4. Pantel, K., Brakenhoff, R. H. & Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8, 329-340 (2008).
5. Liberko, M., Kolostova, K. & Bobek, V. Essentials of circulating tumor cells for clinical research and practice. Crit Rev Oncol Hematol 88, 338-356 (2013).
6. den Toonder, J. Circulating tumor cells: the Grand Challenge. Lab Chip 11, 375-377 (2011).
7. Alix-Panabières, C., Schwarzenbach, H. & Pantel, K. Circulating Tumor Cells and Circulating Tumor DNA. Annu Rev Med 63, 199-215 (2012).
8. Chen, J., Li, J. & Sun, Y. Microfluidic approaches for cancer cell detection, characterization, and separation. Lab Chip 12, 1753-1767 (2012).
9. Arya, S. K., Lim, B. & Rahman, A. R. A. Enrichment, detection and clinical significance of circulating tumor cells. Lab Chip 13, 1995-2027 (2013).
10. Lara, O., Tong, X. D., Zborowski, M. & Chalmers, J. J. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. Exp Hematol 32, 891-904 (2004).
11. Hyun, K.-A., Lee, T. Y. & Jung, H.-I. Negative Enrichment of Circulating Tumor Cells Using a Geometrically Activated Surface Interaction Chip. Anal Chem 85, 4439-4445 (2013).
12. Yang, L. et al. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng 102, 521-534 (2009).
13. Huang, Y.-y. et al. Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system. Biomed Microdevices 15, 673-681 (2013).
14. Li, P., Stratton, Z. S., Dao, M., Ritz, J. & Huang, T. J. Probing circulating tumor cells in microfluidics. Lab Chip 13, 602-609 (2013).
15. Wang, L., Asghar, W., Demirci, U. & Wan, Y. Nanostructured substrates for isolation of circulating tumor cells. Nano Today 8, 374-387 (2013).
16. Zhang, N. et al. Electrospun TiO2 Nanofiber-Based Cell Capture Assay for Detecting Circulating Tumor Cells from Colorectal and Gastric Cancer Patients. Adv Mater 24, 2756-2760 (2012).
17. Stott, S. L. et al. Isolation of circulating tumor cells using amicrovortex-generating herringbone-chip. Proc Natl Acad Sci 107, 18392-18397 (2010).
18. Ozkumur, E. et al. Inertial Focusing for Tumor Antigen-Dependent and - Independent Sorting of Rare Circulating Tumor Cells. Sci Transl Med 5, 179ra147, 1-11 (2013).
19. Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239 (2007).
20. Yu, M. et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition. Science 339, 580-584 (2013).
21. Stott, S. L. et al. Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer. Sci Transl Med 2, 25ra23, 1-10 (2010).
22. Maheswaran, S. et al. Detection of mutations in EGFR in circulating lung-cancer cells. NEJM 359, 366-377 (2008).
23. Gach, P. C., Attayek, P. J., Whittlesey, R. L., Yeh, J. J. & Allbritton, N. L. Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma. Biosens Bioelectron 54, 476-483 (2014).
24. Shaffer, D. R. et al. Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer. Clin Cancer Res 13, 2023-2029 (2007).
25. Cristofanilli, M. et al. Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer. NEJM 351, 781-791 (2004).
26. Cohen, S. J. et al. Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer. J Clin Oncol 26, 3213-3221 (2008).
27. Harouaka, R. A., Nisic, M. & Zheng, S.-Y. Circulating Tumor Cell Enrichment Based on Physical Properties. J Lab Autom 18, 455-468 (2013).
28. Shim, S. et al. Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis. Biomicrofluidics 7, 011807, 1-12 (2013).
29. Baccelli, I. et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotech 31, 539-544 (2013).
30. Fischer, J. C. et al. Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients. Proc Natl Acad Sci 110, 16580-16855 (2013).
31. Sollier, E. et al. Size-selective collection of circulating tumor cells using Vortex technology. Lab Chip 14, 63-77 (2014).
32. Samlowski, W. E., McGregor, J. R., Tharkar, S., Donepudi, S. & Ferrone, S. Isolation and Expansion of Circulating Tumor Cells (CTC) from Melanoma Patients Using a Novel Cell Culture Technique. J Clin Oncol 30, abstr 10614 (2012).
33. Donepudi, S. et al. Circulating Tumor Cell Cultures as a Predictive Marker during Salvage Therapy of Refractory Merkel Cell Carcinoma with Chemotherapy and Electron Beam Radiation. JCT 4, 1162-1166 (2013).
34. Zhang, L. et al. The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis. Sci Transl Med 5, 180ra148 (2013).
35. Kirby, B. J. et al . Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device. PLoS ONE 7, e35976, 1-10 (2012).
36. Zheng, S. et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr 1162, 154-161 (2007).
37. Zheng, S. et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed Microdevices 13, 203-213 (2011).
38. Harouaka, R. A. et al. Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells. Clin Chem 60, 323-333 (2014).
39. Kojima, T. et al. A simple biological imaging system for detecting viable human circulating tumor cells. JCI 119, 3172-3181 (2009).
40. Pulaski, B. A. & Ostrand-Rosenberg, S. in Curr Protoc Immunol (John Wiley &Sons, Inc., Hoboken, NJ, 2001).
41. Königsberg, R. et al. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncol 50, 700-710 (2011).
42. Attard, G. & de Bono, J. S. Utilizing circulating tumor cells: challenges and pitfalls. Curr Opin Genet Dev 21, 50-58 (2011).
43. Went, P. T. H. et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 35, 122-128 (2004).
44. Rao, C. G. et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 27, 49-57 (2005).
45. Fleischer, R. L., Price, P. B. & Symes, E. M. Novel Filter for Biological Materials. Science 143, 249-250 (1964).
46. Lin, H. K. et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 16, 5011-5018 (2010).
47. Wolfensohn, S. & Lloyd, M. Handbook of Laboratory Animal Management and Welfare, 4th Edition. (Wiley-Blackwell, Hoboken, NJ, 2013).
48. Yu, M. et al. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345, 216-220 (2014).
49. Ince, T. A. et al. Transformation of Different Human Breast Epithelial Cell Types Leads to Distinct Tumor Phenotypes. Cancer Cell 12, 160-170 (2007).
50. Liu, X. et al. ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells. Am J Pathol 180, 599-607 (2012).
51. Yuan, H. et al . Use of Reprogrammed Cells to Identify Therapy for Respiratory Papillomatosis. NEJM 367, 1220-1227 (2012).